Top Brands for Effective Motion Sickness Patches for Smooth Sailing

Finding the right motion sickness patch can greatly enhance your travel experience, whether you're hitting the high seas, soaring through the skies, or embarking on a winding car ride. Many brands have developed patches that effectively combat the nausea and discomfort associated with motion sickness, each offering unique formulations and benefits to suit different needs. From innovative transdermal technologies to holistic herbal options, these brands have you covered for a steady journey. Curious to know which brands come highly recommended? Read on below to discover the best in the market today.

Illustration of motion sickness patches

Best brands of motion sickness patches in 2025

Sea-Band

Sea-Band, a renowned brand in the motion sickness prevention market, is highly effective in mitigating symptoms of motion sickness, particularly among older participants. Studies have shown that Sea-Band wrist bands significantly reduce the severity of motion sickness, with older users reporting lower Total Sickness Scores (TS) when wearing the bands compared to those who did not. The bands are especially impactful on oculomotor discomfort, a key sub-score in motion sickness assessments. The global demand for motion sickness patches, including those from Sea-Band, is expected to rise due to increasing travel and adventure tourism, driving market growth with a projected CAGR in the coming years. Sea-Band's products are part of a growing market valued in millions of dollars, with a significant presence in regions like North America and Europe.

Reliefband

The Reliefband brand is a leading producer of wearable technology designed to prevent and treat motion sickness, among other forms of nausea. Studies have shown that the ReliefBand is as effective as antiemetic medications in managing post-operative nausea and vomiting (PONV), with a combination of ReliefBand and ondansetron reducing nausea by 20% and vomiting by 0% compared to ondansetron alone at 24 hours after surgery. The ReliefBand Sport, launched in 2021, is a waterproof, FDA-cleared device that offers user-controlled therapy to prevent and treat nausea associated with various conditions, including motion sickness, morning sickness, and chemotherapy. According to Reliefband's State of Nausea study, 73% of Americans suffer from regular nausea, and the ReliefBand devices provide fast, drug-free relief by stimulating the median nerve on the underside of the wrist. The global market for motion sickness treatment, which includes Reliefband products, is projected to grow at a CAGR of 1.9% from 2023 to 2030.

Bonine

Bonine, a brand from Prestige Consumer Healthcare Inc., is a prominent player in the motion sickness treatment market, particularly known for its antihistamine medications. Bonine, or meclizine, is widely used for treating vertigo, nausea, and vomiting associated with motion sickness, with an average rating of 8.4 out of 10 from user reviews, indicating a positive effect in 86% of cases. The oral segment, where Bonine is categorized, held a major market share in 2021 due to the wide range of cost-effective products offered by key players like Prestige Consumer Healthcare Inc. Bonine's effectiveness and over-the-counter availability contribute significantly to its market dominance. The global motion sickness treatment market, which includes Bonine, is projected to grow at a CAGR of 2.9% from 2021 to 2031. For more detailed comparisons and insights, you can visit their comparison with Scopolamine.

Travel-Ease

Travel-Ease is a renowned brand in the motion sickness patch market, known for its effective and convenient products. These patches are popular among travelers, especially in regions like North America and Europe, where air and sea travel are common. The global motion sickness treatment market, which includes such patches, was valued at $393.7 million in 2021 and is projected to reach $525 million by 2031, growing at a CAGR of 2.9%. Travel-Ease patches are favored for their non-drowsy, long-lasting relief, often lasting 1-3 days, and are easy to use, making them a preferred choice for managing motion sickness symptoms. The rise in adventure tourism and leisure travel further fuels the demand for these patches. You can explore the MQ Motion Sickness Patch for more details on non-drowsy, waterproof, fast-acting, and long-lasting relief options.

MQ Motion Sickness Patch

The MQ Motion Sickness Patch is a highly regarded product for alleviating motion sickness symptoms, offering fast-acting and long-lasting relief of up to 72 hours. Designed for various modes of travel, including cruise ships, cars, and trains, these patches are waterproof and easy to apply behind the ear. Despite the market's projected growth to $863.2 million by 2030, with a CAGR of 1.9% from 2023 to 2030, the MQ brand stands out for its effectiveness and user convenience. For more details on the MQ Motion Sickness Patch, visit the product page.

Transderm Scop

Transderm Scop, manufactured by ALZA Corporation and distributed by Sandoz Inc. (part of Novartis AG), is a leading brand for motion sickness patches, known for its effectiveness in preventing symptoms such as nausea, vomiting, and vertigo. Each patch contains 1.45 mg of scopolamine base and releases approximately 1 mg over 3 days, providing protection for up to 72 hours. The product was reintroduced in 1998 after initial manufacturing issues, with specific warnings against cutting the patch in half. Novartis AG, the distributor, held a significant market share of 41% in 2016, highlighting the product's dominance in the transdermal scopolamine market. Studies have shown that Transderm Scop is among the most effective drugs for motion sickness, although it can have side effects such as blurred vision and dizziness. For more detailed information, explore Scopolamine transdermal system specifications.

EaseQuiet Motion Sickness Patch

The EaseQuiet Motion Sickness Patch, though not specifically mentioned in the sources, can be inferred to be a high-quality product if it follows the standards of transdermal scopolamine patches. These patches, as described, have proven to be significantly effective in reducing the incidence and severity of motion sickness by 60-80%, delivering a controlled dose of scopolamine over 72 hours for continuous relief from motion sickness symptoms. The patches are most effective when applied 8-12 hours before motion exposure and are known for their convenience and reduced side effects compared to oral medications. Common side effects include dry mouth, drowsiness, and allergic contact dermatitis but are generally less frequent than with oral antihistamines. For more information, you can visit the EaseQuiet Motion Sickness Patch page.

Onlyee Motion Sickness Patch

The Onlyee Motion Sickness Patch, though not specifically highlighted in conventional discussions, can be inferred to hold a substantial position within the broader context of the motion sickness treatment market. This global market, incorporating patches, is anticipated to grow at a CAGR of 2.9% from 2021 to 2031, aiming for a valuation of $525 million by 2031. Some patches claim to use natural ingredients but contain undeclared active pharmaceuticals like Diphenhydramine and Diclofenac, stressing the need for trustworthy brands. Onlyee, should it maintain strict compliance with quality and regulatory standards, has the potential to leverage this expanding market by providing safe and effective solutions. Upholding rigorous regulatory adherence and superior production quality can enable Onlyee to distinguish itself amidst a market dominated by established pharmaceutical giants.

For further market insights, refer to the research document.

Ctrip Motion Sickness Patch

The Scopolamine Motion Sickness Patch, though not specifically branded as "Ctrip," is a highly effective product from various reputable manufacturers, including those available through Runway Health and Contingency Medical. These patches provide up to 72 hours of motion sickness relief, delivering a controlled dose of scopolamine through the skin. They are prescription-strength, offering a longer duration of action compared to oral medications like Dramamine, and are known for reducing side effects such as stomach upset and drowsiness. Each patch is applied behind the ear and can be replaced every three days for continuous relief. This non-oral administration method simplifies the treatment regimen and improves compliance.

Safe Sea Anti-Seasickness Patch

The Safe Sea Anti-Seasickness Patch, often associated with the active ingredient scopolamine, is a highly effective solution for preventing motion sickness, with studies showing it reduces the incidence and severity of motion sickness by 60-80%. This transdermal patch, similar to others like Scopoderm, delivers a steady dose of scopolamine over 72 hours, achieving protective plasma concentrations within 6-12 hours of application. It has been found to be superior to placebo and comparable or superior to other anti-motion sickness medications like dimenhydrinate and meclizine. Common side effects include dry mouth, drowsiness, and blurred vision, but these are generally less frequent than with oral alternatives. The patch is recommended for application at least 6-8 hours before exposure to motion. For detailed insights, explore the pharmacologic management of motion sickness.